Lista de obras - Caterina Gori - Dominio Público Uruguay

'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing.

artículo científico publicado en 2011

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

artículo científico publicado en 2014

An HIV type 2 case series in Italy: a phylogenetic analysis

artículo científico publicado en 2013

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

artículo científico publicado en 2014

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy

scientific article published on 10 May 2019

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs

artículo científico publicado en 2009

Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study

artículo científico publicado en 2013

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

artículo científico publicado en 2017

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

artículo científico publicado en 2012

Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.

artículo científico publicado en 2004

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome

article

Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay

artículo científico

Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence

artículo científico publicado en 2018

Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia

artículo científico publicado en 2015

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.

artículo científico

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia

artículo científico publicado en 2015

High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations

artículo científico publicado en 2005

Historical resistance profile helps to predict salvage failure.

artículo científico

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.

artículo científico publicado en 2004

Impact of pre-therapy viral load on virological response to modern first-line HAART.

artículo científico

Is extended resistance to the historical antiretroviral drugs & drug classes still a risk factor for HIV progression?

artículo científico publicado en 2010

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia

artículo científico publicado en 2010

Molecular Diversity of HIV in Albania

article

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

artículo científico publicado en 2005

No significant association between patient self-reported non-adherence to antiretrovirals and HIV-tropism: a preliminary analysis

article

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection

article

Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors

artículo científico publicado en 2005

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.

artículo científico publicado en 2011

Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART

article

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients

artículo científico publicado en 2014

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

artículo científico publicado en 2004

Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy

artículo científico publicado en 2015

Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels

artículo científico publicado en 2014

Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment

artículo científico publicado en 2018

Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development

artículo científico publicado en 2011

Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen

artículo científico publicado en 2013

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme

artículo científico publicado en 2005

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy

article

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro

artículo científico publicado en 2016

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

artículo científico publicado en 2003

The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing

artículo científico publicado en 2013

The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.

artículo científico publicado en 2012

The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes

artículo científico publicado en 2008

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

artículo científico publicado en 2003

Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

artículo científico publicado en 2002

Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.

artículo científico publicado en 2016

gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure

artículo científico publicado en 2007

Lista de obras de Caterina Gori

'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing.

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

An HIV type 2 case series in Italy: a phylogenetic analysis

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs

Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy

Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome

Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay

Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence

Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia

High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations

Historical resistance profile helps to predict salvage failure.

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.

Impact of pre-therapy viral load on virological response to modern first-line HAART.

Is extended resistance to the historical antiretroviral drugs & drug classes still a risk factor for HIV progression?

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia

Molecular Diversity of HIV in Albania

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

No significant association between patient self-reported non-adherence to antiretrovirals and HIV-tropism: a preliminary analysis

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection

Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.

Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy

Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels

Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment

Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development

Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing

The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.

The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.

gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure